Society for Immunotherapy of Cancer (SITC)-36th Annual Meeting

The Society for Immunotherapy of Cancer (SITC)'s annual meeting is the largest cancer immunotherapy conference, bringing together a multidisciplinary panel of experts. This year, in its 36th edition, it was run as a hybrid event attended simultaneously by both in-person attendees at the Walter E. Washington Convention Center in Washington, D.C., and virtual attendees, from November 10 to 14. The meeting categories were separated into clinical trial abstracts (in progress and completed) and nonclinical trial abstracts, covering topics such as cellular therapies, immune-conjugates and chimeric molecules, checkpoint blockade therapy, immunotherapy toxicities and biomarkers, and others. This report covers some key highlights of the meeting.